Send a message to the show! Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities but also increased the stakes. How do we use them without losing trust and where do we set the limits? In this two-part epi ... Show More
Feb 2026
#44 Rethinking medical device safety, part 2 – Omar Aimer
Send a message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can put patients at risk. In this two-part episode, Omar Aimer, President of ISoP and former co ... Show More
21m 22s
Apr 2021
Clinical Implications & Application of Pharmacogenomics | PGX for Pharmacists
Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, joins Cari Lalande, PharmD where we discuss the clinical value and utility of PGx and how it can be implemented in a clinical setting.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. ... Show More
24m 6s
May 2022
Patient-Reported Outcomes in Clinical Trials
<p>JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ... Show More
14m 26s